As of Mar 24
| +0.025 / +0.46%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 12.13, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +123.50% increase from the last price of 5.43.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.